Figure 3. Expression of glutamine metabolism-related proteins according to the BRAF V600E mutation status in papillary thyroid cancer.
Papillary thyroid cancer with the BRAF V600E mutation shows higher expression of tumoral GLS1, tumoral GDH, and tumoral ASCT2. GLS1; glutaminase 1, GDH; glutamate dehydrogenase, ASCT2; amino acid transporter-2